L&C Bio Co. Ltd (290650) — Cash Flow Quality Index
L&C Bio Co. Ltd (290650) has a Cash Flow Quality Index of -0.06x as of December 2024. Operating cash flow of ₩-8.57 Billion is below net income of ₩140.97 Billion, suggesting accrual-heavy earnings not yet converted to cash. Also explore L&C Bio Co. Ltd balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
L&C Bio Co. Ltd Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for L&C Bio Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check L&C Bio Co. Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for L&C Bio Co. Ltd (2015–2024)
Year-by-year earnings quality comparison for L&C Bio Co. Ltd. For live market cap and the full company financial profile, see L&C Bio Co. Ltd stock valuation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | ₩-8.57 Billion | ₩140.97 Billion | ▲ +75.8% |
| 2023 | -0.25x | ₩-12.13 Billion | ₩48.36 Billion | ▲ +81.2% |
| 2022 | -1.34x | ₩-6.08 Billion | ₩4.54 Billion | ▼ -279.5% |
| 2021 | 0.74x | ₩10.91 Billion | ₩14.65 Billion | ▲ +22.0% |
| 2020 | 0.61x | ₩7.42 Billion | ₩12.15 Billion | ▼ -31.2% |
| 2019 | 0.89x | ₩6.43 Billion | ₩7.25 Billion | ▲ +20.1% |
| 2018 | 0.74x | ₩3.85 Billion | ₩5.21 Billion | ▼ -27.4% |
| 2017 | 1.02x | ₩3.82 Billion | ₩3.75 Billion | ▲ +1187.4% |
| 2016 | -0.09x | ₩-185.35 Million | ₩1.98 Billion | ▲ +91.5% |
| 2015 | -1.10x | ₩-1.33 Billion | ₩1.20 Billion | — |